Data: 25/27-9-2015
Luogo: Parigi (Francia), Novotel Tour Eiffel Hotel
Chairman: Simon Fishel comtecmed.com
|
Saturday, September 26, 2015
|
|
| Session 1 Introduction to Genetics | |
| Welcome Simon Fishel, UK | |
| Basic principles for the non-geneticist Brigitte Faas, The Netherlands | |
| Next generation sequencing: strategies for genetic testing Mark Hughes, USA | |
| Technical aspects of reproductive genetics (Methods of PGS, PGD, Prenatal) Darren Griffin, UK | |
| Carrier screening of recessive disease: Universal screening Gabriel Lazarin, USA | |
| Session 2 PGD and PGS: State-of-the-Art | |
| Development and current best practice for translocations Svetlana Rechitsky, USA | |
| Single gene diagnosis and aneuploidy detection using karyomapping Tony Gordon, UK | |
| Clinically evaluating NGS and its extra information Dagan Wells, UK | |
| PGS for advanced maternal age Ariel Hourvitz, Israel | |
| Session 3 The clinical value of Preimplantation Genetic Screening (PGS) | |
| Management of PGS treatment embryo: timing, technology, success and cost effectiveness Richard Scott, USA | |
| Aneuploidy in embryos: variability between centers, between patients and between cycles of the same patients Santiago Munné, USA | |
| Debate: Is it now unethical not to screen out an aneuploidy embryo in IVF? For: Andreas Schmutzler, Germany Against: Sjoerd Repping, The Netherlands | |
| Session 4 Prediction of Gamete quality and viability | |
| Cumulus cell genomics and its predictive value Samir Hamamah, France | |
| Blastocoel analysis for PGS and the potential clinical value of mitochondrial screening assays Luca Gianaroli, Italy | |
| Ultra-sensitive mass spectrometry to look at the proteomic content of the blastocoel fluid with a view to embryo viability assessment Maurizio Poli, UK | |
| Update on polar body testing for detection of female meiotic errors Alan Handyside, UK | |
|
Sunday, September 27, 2015
|
|
| Session 5 Non-Invasive Prenatal Testing (NIPT): Current state of the ART | |
| Introduction of NIPT in clinical practice Dick Oepkes, The Netherlands | |
| Debate : How should NIPT be used Moderator: Dick Oepkes, The Netherlands – As primary screening to all patients Tom Musci, USA– As contingent screening in very high and intermediate risk patients Howard Cuckle, USA/Israel | |
| Session 6 Non-Invasive Prenatal Testing (NIPT): Future Perspectives | |
| Debate: NIPT for microdeletion syndromes Pros: Amy Sehnert, USA Cons: Tom Musci, USA | |
| NIPT for Single-Gene Disorders Lyn Chitty, UK | |
| Future development in NIPT Rossa W.K. Chiu, Hong Kong | |
|
Session 7 Chromosomal microarrays (CMA) in Prenatal Diagnosis
|
|
| Chromosomal microarrays – how does it work? Vincenzo Cirigliano, Spain | |
| Can CMA replace standard karyotyping? Francesco Fiorentino, Italy | |
| Counseling for Variants of Unclear Clinical Significance Brigitte Faas, The Netherlands | |
| Debate: Would it be ethical not to propose women to undergo invasive testing with CMA? Moderator: TBD For: TBD Against: Yuval Yaron, Israel | |
| Session 8 Genetics in infertility | |
| Characterization of the molecular etiology of severe cases of infertility – a must to bring personalized medicine to the field of reproduction Pierre Ray, France | |
| Carrier screening of genes relevant in infertility, including mutations associated with miscarriage Alex Bisignano, USA | |
| Gene therapy in reproductive medicine Gregory Christman, USA | |
| Social and legal aspects Francoise Shenfield, UK | |
Contact Comtec Med
info@comtecmed.com comtecmed.com
